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Abstract
There is a high incidence of staphylococcal infection in children with dermatomyositis, which is limited to those children who either already have or subsequently develop calcinosis. Of 15 children followed up for [3] [4] [5] [6] [7] [8] [9] [10] years after diagnosis, all nine who developed calcinosis had infections with Staphylococcus aureus compared with none of six without calcinosis. Of these nine, the occurrence of staphylococcal infections before calcinosis was observed in four, suggested by history in two, and unclear in three children.
Granulocyte chemotaxis to Staphylococcus aureus was more severely depressed in those children with calcinosis, whereas those without calcinosis did not differ significantly from controls. The chemotactic defect was due to a serum factor (patients' serum depressed control chemotaxis and control serum corrected the patients' chemotaxis).
The nine children with calcinosis also had significantly higher serum IgE concentrations than non-atopic age matched controls; the six without calcinosis did not differ from controls. The increased IgE concentrations appeared to develop after staphylococcal infection and before calcinosis. Two of five patients with calcinosis had increased antistaphylococcal IgE antibodies; neither of the two patients without calcinosis had such increased antibodies. This suggests preceding immunological differences in patients with dermatomyositis who do and do not subsequently develop calcinosis, either increasing susceptibility to Staphylococcus aureus infection or potentially resulting from such infections.
There is a high incidence of Staphylococcus aureus infection in patients with childhood dermatomyositis, often mentioned in passing in case reports'-9 but to our knowledge the subject of no prior systematic investigation. In studying the cause of this predilection, we noted that the staphylococcal infection occurred only in those children who already had, or subsequently developed, calcinosis and that, although infection of calcinosis sites sometimes occurred, the sites of infection and sites of calcinosis were usually different. Clinical and immunological differences to explain this were sought.
Patients and methods

PATIENTS
We studied 15 patients with clinically typical childhood dermatomyositis, with increased levels of muscle enzymes (creatine kinase, lactate dehydrogenase, aldolase, serum aspartate aminotransferase (AST)) at some point in their disease course and with consistent findings on electromyography and muscle biopsy. Seven patients were white and eight black; nine were girls and six boys, consistent with previous reports of childhood 'dermatomyositis.
At the end of the observation period, the children were divided into two groups: nine in group 1, who had developed calcinosis and six in group 2 who had not developed calcinosis; patients were screened at each visit for calcinosis by careful palpation, with suspicious areas confirmed radiographically. The two groups of patients (with and without calcinosis) were followed up for 3-10 years, although only tests performed on patients with childhood dermatomyositis with active disease (i.e. either before treatment or still requiring treatment) were considered in this study. The two groups did not differ in age at presentation or in race. There was a higher percentage of boys in the group with calcinosis (five of nine in group 1 v one of six in group 2), but this was not statistically significant in view of the small sample size. There was no significant difference in the duration of disease from onset to treatment between the two groups or in the apparent severity of disease at the time of presentation. Table 1 , however, shows that the disease was more prolonged in group 1 patients, with many requiring treatment for several years after the initial presentation. Table 2 shows that enzyme levels remained raised for prolonged periods of time in group 1 patients but returned to normal within three months for all group 2 patients.
The initially prescribed corticosteroid treatment did not differ between the two groups, but treatment was longer in group 1 patients, with a higher level of non-compliance. Two group 1 patients were also prescribed cytotoxic drugs later in their illness; only one of these was tested during this period. Two patients in group 1 and one in group 2 had a recurrence of the disease after an initial response.
METHODS
IgE concentrations were measured by radioimmunoassay using kits from Pharmacia, (Piscataway, NY, USA) or Behring Diagnostics (La Jolla, CA, USA). Results from the two kits were consistent except for minimal differences at high concentrations.
The control children had uncomplicated monarticular or pauciarticular juvenile rheuma- Figure 1 shows the results of determinations in 29 14 though primarily by affecting the cells, but correlation with the prednisone dose at the time of testing or over the previous three and six months was very weak (r=0-49 and r=0 48, respectively), and some patients receiving no treatment had very abnormal chemotaxis. The one patient tested while receiving azathioprine had normal and abnormal results.
As a result of the known association of recurrent staphylococcal infection and chemotactic defects in the hyper IgE syndrome, we also studied the IgE concentrations in the two groups of patients. Figure 3 shows that despite considerable overlap, the mean IgE concentrations were significantly higher (p<0-01, Student's t test) in group 1 (with calcinosis) than in age matched non-allergic children or in the group 2 patients (without calcinosis).
The IgE concentrations in group 1 children varied widely over the course of their illness, tending to become higher as the disease progressed, though some were raised at presentation. Figure 4 
